Prognosis of patients treated for Cushing syndrome
Endocrinol Nutr. 2014 Jan;61(1):52-61.
doi: 10.1016/j.endonu.2013.03.008.
Epub 2013 Jul 3.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Endocrinología, Departamento de Medicina, Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, España. Electronic address: aaulinasm@gmail.com.
- 2 Institut d'Investigació Biomèdica Sant Pau, Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBER-ER, Unidad 747), Instituto de Salud Carlos III, Barcelona, España.
- 3 Servicio de Endocrinología, Departamento de Medicina, Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, España; Institut d'Investigació Biomèdica Sant Pau, Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBER-ER, Unidad 747), Instituto de Salud Carlos III, Barcelona, España.
Abstract
Cushing syndrome (CS), due to an ACTH-secreting pituitary adenoma, adrenal tumors, or ectopic ACTH secretion, causes hypercortisolism. CS is associated with major morbidity, especially metabolic and cardiovascular complications, osteoporosis, psychiatric changes, and cognitive impairment. Despite biochemical "cure" of hypercortisolism and clinical improvement after effective treatment, these complications are only partially reversible. Exacerbation of prior autoimmune diseases is also seen. All of these lead to quality of life impairment and increased mortality. This review addresses the main comorbidities and long-term consequences of CS despite clinical and biochemical "cure".
Keywords:
Calidad de vida relacionada con la salud; Cardiovascular risk; Cushing disease; Cushing syndrome; Enfermedad de Cushing; Health-related quality of life; Mortalidad; Mortality; Osteoporosis; Remisión; Remission; Riesgo cardiovascular; Síndrome de Cushing.
Copyright © 2013 SEEN. Published by Elsevier Espana. All rights reserved.
MeSH terms
-
ACTH-Secreting Pituitary Adenoma / complications
-
ACTH-Secreting Pituitary Adenoma / surgery
-
Adrenal Cortex Neoplasms / complications
-
Adrenal Cortex Neoplasms / surgery
-
Adrenalectomy
-
Adrenocortical Adenoma / complications
-
Adrenocortical Adenoma / surgery
-
Adrenocorticotropic Hormone / metabolism
-
Cushing Syndrome / etiology
-
Cushing Syndrome / physiopathology
-
Cushing Syndrome / therapy*
-
Humans
-
Hydrocortisone / metabolism
-
Hypophysectomy*
-
Pituitary ACTH Hypersecretion / complications
-
Pituitary ACTH Hypersecretion / surgery
-
Pituitary Neoplasms / complications
-
Pituitary Neoplasms / surgery
-
Pituitary-Adrenal System / physiopathology
-
Prognosis
-
Quality of Life
Substances
-
Adrenocorticotropic Hormone
-
Hydrocortisone